nodes	percent_of_prediction	percent_of_DWPC	metapath
Remifentanil—OPRK1—Progesterone—uterine cancer	0.72	1	CbGbCtD
Remifentanil—Anxiety—Medroxyprogesterone Acetate—uterine cancer	0.000896	0.0032	CcSEcCtD
Remifentanil—Unspecified disorder of skin and subcutaneous tissue—Medroxyprogesterone Acetate—uterine cancer	0.000893	0.00319	CcSEcCtD
Remifentanil—Hypotension—Progesterone—uterine cancer	0.000888	0.00318	CcSEcCtD
Remifentanil—Dry mouth—Medroxyprogesterone Acetate—uterine cancer	0.000879	0.00314	CcSEcCtD
Remifentanil—Flushing—Dactinomycin—uterine cancer	0.000878	0.00314	CcSEcCtD
Remifentanil—Confusional state—Medroxyprogesterone Acetate—uterine cancer	0.000869	0.00311	CcSEcCtD
Remifentanil—Oedema—Medroxyprogesterone Acetate—uterine cancer	0.000862	0.00308	CcSEcCtD
Remifentanil—Anaphylactic shock—Medroxyprogesterone Acetate—uterine cancer	0.000862	0.00308	CcSEcCtD
Remifentanil—Dysphagia—Etoposide—uterine cancer	0.000855	0.00306	CcSEcCtD
Remifentanil—Paraesthesia—Progesterone—uterine cancer	0.000854	0.00305	CcSEcCtD
Remifentanil—Chills—Dactinomycin—uterine cancer	0.000849	0.00304	CcSEcCtD
Remifentanil—Dyspnoea—Progesterone—uterine cancer	0.000848	0.00303	CcSEcCtD
Remifentanil—Shock—Medroxyprogesterone Acetate—uterine cancer	0.000848	0.00303	CcSEcCtD
Remifentanil—Ventricular extrasystoles—Epirubicin—uterine cancer	0.000846	0.00303	CcSEcCtD
Remifentanil—Somnolence—Progesterone—uterine cancer	0.000845	0.00302	CcSEcCtD
Remifentanil—Nervous system disorder—Medroxyprogesterone Acetate—uterine cancer	0.000845	0.00302	CcSEcCtD
Remifentanil—Thrombocytopenia—Medroxyprogesterone Acetate—uterine cancer	0.000844	0.00302	CcSEcCtD
Remifentanil—Bronchospasm—Etoposide—uterine cancer	0.000841	0.00301	CcSEcCtD
Remifentanil—Tachycardia—Medroxyprogesterone Acetate—uterine cancer	0.000841	0.00301	CcSEcCtD
Remifentanil—Dyspepsia—Progesterone—uterine cancer	0.000837	0.00299	CcSEcCtD
Remifentanil—Skin disorder—Medroxyprogesterone Acetate—uterine cancer	0.000837	0.00299	CcSEcCtD
Remifentanil—Hyperhidrosis—Medroxyprogesterone Acetate—uterine cancer	0.000833	0.00298	CcSEcCtD
Remifentanil—Oliguria—Epirubicin—uterine cancer	0.000829	0.00297	CcSEcCtD
Remifentanil—Erythema—Dactinomycin—uterine cancer	0.000823	0.00295	CcSEcCtD
Remifentanil—Gastrointestinal disorder—Progesterone—uterine cancer	0.000821	0.00294	CcSEcCtD
Remifentanil—Dyskinesia—Epirubicin—uterine cancer	0.000813	0.00291	CcSEcCtD
Remifentanil—Pain—Progesterone—uterine cancer	0.000813	0.00291	CcSEcCtD
Remifentanil—Constipation—Progesterone—uterine cancer	0.000813	0.00291	CcSEcCtD
Remifentanil—Hypotension—Medroxyprogesterone Acetate—uterine cancer	0.000805	0.00288	CcSEcCtD
Remifentanil—Atrioventricular block—Epirubicin—uterine cancer	0.000788	0.00282	CcSEcCtD
Remifentanil—Feeling abnormal—Progesterone—uterine cancer	0.000784	0.0028	CcSEcCtD
Remifentanil—Ventricular extrasystoles—Doxorubicin—uterine cancer	0.000783	0.0028	CcSEcCtD
Remifentanil—Paraesthesia—Medroxyprogesterone Acetate—uterine cancer	0.000774	0.00277	CcSEcCtD
Remifentanil—Dyspnoea—Medroxyprogesterone Acetate—uterine cancer	0.000768	0.00275	CcSEcCtD
Remifentanil—Oliguria—Doxorubicin—uterine cancer	0.000767	0.00274	CcSEcCtD
Remifentanil—Pneumonia—Etoposide—uterine cancer	0.000767	0.00274	CcSEcCtD
Remifentanil—Somnolence—Medroxyprogesterone Acetate—uterine cancer	0.000766	0.00274	CcSEcCtD
Remifentanil—Hiccups—Epirubicin—uterine cancer	0.000764	0.00273	CcSEcCtD
Remifentanil—Anaemia—Dactinomycin—uterine cancer	0.000761	0.00272	CcSEcCtD
Remifentanil—Dyspepsia—Medroxyprogesterone Acetate—uterine cancer	0.000758	0.00271	CcSEcCtD
Remifentanil—Urticaria—Progesterone—uterine cancer	0.000755	0.0027	CcSEcCtD
Remifentanil—Dyskinesia—Doxorubicin—uterine cancer	0.000752	0.00269	CcSEcCtD
Remifentanil—Body temperature increased—Progesterone—uterine cancer	0.000752	0.00269	CcSEcCtD
Remifentanil—Hyperkalaemia—Epirubicin—uterine cancer	0.000751	0.00269	CcSEcCtD
Remifentanil—Renal failure—Etoposide—uterine cancer	0.00075	0.00268	CcSEcCtD
Remifentanil—Gastrointestinal disorder—Medroxyprogesterone Acetate—uterine cancer	0.000744	0.00266	CcSEcCtD
Remifentanil—Constipation—Medroxyprogesterone Acetate—uterine cancer	0.000737	0.00264	CcSEcCtD
Remifentanil—Atrioventricular block—Doxorubicin—uterine cancer	0.000729	0.00261	CcSEcCtD
Remifentanil—Feeling abnormal—Medroxyprogesterone Acetate—uterine cancer	0.00071	0.00254	CcSEcCtD
Remifentanil—Hiccups—Doxorubicin—uterine cancer	0.000707	0.00253	CcSEcCtD
Remifentanil—Hypersensitivity—Progesterone—uterine cancer	0.000701	0.00251	CcSEcCtD
Remifentanil—Hyperkalaemia—Doxorubicin—uterine cancer	0.000695	0.00248	CcSEcCtD
Remifentanil—Urticaria—Medroxyprogesterone Acetate—uterine cancer	0.000684	0.00245	CcSEcCtD
Remifentanil—Body temperature increased—Medroxyprogesterone Acetate—uterine cancer	0.000681	0.00244	CcSEcCtD
Remifentanil—Pulmonary oedema—Epirubicin—uterine cancer	0.00068	0.00243	CcSEcCtD
Remifentanil—Pruritus—Progesterone—uterine cancer	0.000673	0.00241	CcSEcCtD
Remifentanil—Oedema—Dactinomycin—uterine cancer	0.000672	0.0024	CcSEcCtD
Remifentanil—Thrombocytopenia—Dactinomycin—uterine cancer	0.000658	0.00235	CcSEcCtD
Remifentanil—Diarrhoea—Progesterone—uterine cancer	0.000651	0.00233	CcSEcCtD
Remifentanil—Flushing—Etoposide—uterine cancer	0.000635	0.00227	CcSEcCtD
Remifentanil—Cardiac disorder—Etoposide—uterine cancer	0.000635	0.00227	CcSEcCtD
Remifentanil—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.000635	0.00227	CcSEcCtD
Remifentanil—Hepatic function abnormal—Epirubicin—uterine cancer	0.000635	0.00227	CcSEcCtD
Remifentanil—Pulmonary oedema—Doxorubicin—uterine cancer	0.000629	0.00225	CcSEcCtD
Remifentanil—Dizziness—Progesterone—uterine cancer	0.000629	0.00225	CcSEcCtD
Remifentanil—Angiopathy—Etoposide—uterine cancer	0.000621	0.00222	CcSEcCtD
Remifentanil—Immune system disorder—Etoposide—uterine cancer	0.000618	0.00221	CcSEcCtD
Remifentanil—Mediastinal disorder—Etoposide—uterine cancer	0.000617	0.00221	CcSEcCtD
Remifentanil—Chills—Etoposide—uterine cancer	0.000614	0.0022	CcSEcCtD
Remifentanil—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.00061	0.00218	CcSEcCtD
Remifentanil—Vomiting—Progesterone—uterine cancer	0.000605	0.00216	CcSEcCtD
Remifentanil—Rash—Progesterone—uterine cancer	0.000599	0.00214	CcSEcCtD
Remifentanil—Dermatitis—Progesterone—uterine cancer	0.000599	0.00214	CcSEcCtD
Remifentanil—Headache—Progesterone—uterine cancer	0.000596	0.00213	CcSEcCtD
Remifentanil—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.000589	0.00211	CcSEcCtD
Remifentanil—Hepatic function abnormal—Doxorubicin—uterine cancer	0.000587	0.0021	CcSEcCtD
Remifentanil—Renal impairment—Epirubicin—uterine cancer	0.000583	0.00208	CcSEcCtD
Remifentanil—Pain—Dactinomycin—uterine cancer	0.000575	0.00206	CcSEcCtD
Remifentanil—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.00057	0.00204	CcSEcCtD
Remifentanil—Nausea—Progesterone—uterine cancer	0.000565	0.00202	CcSEcCtD
Remifentanil—Feeling abnormal—Dactinomycin—uterine cancer	0.000554	0.00198	CcSEcCtD
Remifentanil—Anaemia—Etoposide—uterine cancer	0.000551	0.00197	CcSEcCtD
Remifentanil—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.000548	0.00196	CcSEcCtD
Remifentanil—Rash—Medroxyprogesterone Acetate—uterine cancer	0.000543	0.00194	CcSEcCtD
Remifentanil—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.000543	0.00194	CcSEcCtD
Remifentanil—Headache—Medroxyprogesterone Acetate—uterine cancer	0.00054	0.00193	CcSEcCtD
Remifentanil—Renal impairment—Doxorubicin—uterine cancer	0.000539	0.00193	CcSEcCtD
Remifentanil—Body temperature increased—Dactinomycin—uterine cancer	0.000531	0.0019	CcSEcCtD
Remifentanil—Cardiac arrest—Epirubicin—uterine cancer	0.000527	0.00189	CcSEcCtD
Remifentanil—Loss of consciousness—Etoposide—uterine cancer	0.000524	0.00187	CcSEcCtD
Remifentanil—Cough—Etoposide—uterine cancer	0.00052	0.00186	CcSEcCtD
Remifentanil—Convulsion—Etoposide—uterine cancer	0.000516	0.00185	CcSEcCtD
Remifentanil—Hypertension—Etoposide—uterine cancer	0.000515	0.00184	CcSEcCtD
Remifentanil—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.000512	0.00183	CcSEcCtD
Remifentanil—Hypokalaemia—Epirubicin—uterine cancer	0.000505	0.00181	CcSEcCtD
Remifentanil—Unspecified disorder of skin and subcutaneous tissue—Etoposide—uterine cancer	0.000504	0.0018	CcSEcCtD
Remifentanil—Nasopharyngitis—Epirubicin—uterine cancer	0.000496	0.00177	CcSEcCtD
Remifentanil—Hypersensitivity—Dactinomycin—uterine cancer	0.000495	0.00177	CcSEcCtD
Remifentanil—Confusional state—Etoposide—uterine cancer	0.00049	0.00175	CcSEcCtD
Remifentanil—Cardiac arrest—Doxorubicin—uterine cancer	0.000488	0.00175	CcSEcCtD
Remifentanil—Anaphylactic shock—Etoposide—uterine cancer	0.000486	0.00174	CcSEcCtD
Remifentanil—Dysphagia—Epirubicin—uterine cancer	0.000479	0.00171	CcSEcCtD
Remifentanil—Thrombocytopenia—Etoposide—uterine cancer	0.000476	0.0017	CcSEcCtD
Remifentanil—Tachycardia—Etoposide—uterine cancer	0.000475	0.0017	CcSEcCtD
Remifentanil—Skin disorder—Etoposide—uterine cancer	0.000472	0.00169	CcSEcCtD
Remifentanil—Hyperhidrosis—Etoposide—uterine cancer	0.00047	0.00168	CcSEcCtD
Remifentanil—Hypokalaemia—Doxorubicin—uterine cancer	0.000467	0.00167	CcSEcCtD
Remifentanil—Bronchitis—Epirubicin—uterine cancer	0.000461	0.00165	CcSEcCtD
Remifentanil—Diarrhoea—Dactinomycin—uterine cancer	0.00046	0.00164	CcSEcCtD
Remifentanil—Nasopharyngitis—Doxorubicin—uterine cancer	0.000459	0.00164	CcSEcCtD
Remifentanil—Hypotension—Etoposide—uterine cancer	0.000454	0.00163	CcSEcCtD
Remifentanil—Dysuria—Epirubicin—uterine cancer	0.000448	0.0016	CcSEcCtD
Remifentanil—Dysphagia—Doxorubicin—uterine cancer	0.000444	0.00159	CcSEcCtD
Remifentanil—Paraesthesia—Etoposide—uterine cancer	0.000437	0.00156	CcSEcCtD
Remifentanil—Dyspnoea—Etoposide—uterine cancer	0.000434	0.00155	CcSEcCtD
Remifentanil—Hyperglycaemia—Epirubicin—uterine cancer	0.000432	0.00155	CcSEcCtD
Remifentanil—Somnolence—Etoposide—uterine cancer	0.000432	0.00155	CcSEcCtD
Remifentanil—Pneumonia—Epirubicin—uterine cancer	0.00043	0.00154	CcSEcCtD
Remifentanil—Vomiting—Dactinomycin—uterine cancer	0.000427	0.00153	CcSEcCtD
Remifentanil—Bronchitis—Doxorubicin—uterine cancer	0.000427	0.00153	CcSEcCtD
Remifentanil—Rash—Dactinomycin—uterine cancer	0.000424	0.00152	CcSEcCtD
Remifentanil—Renal failure—Epirubicin—uterine cancer	0.00042	0.0015	CcSEcCtD
Remifentanil—Gastrointestinal disorder—Etoposide—uterine cancer	0.00042	0.0015	CcSEcCtD
Remifentanil—Pain—Etoposide—uterine cancer	0.000416	0.00149	CcSEcCtD
Remifentanil—Constipation—Etoposide—uterine cancer	0.000416	0.00149	CcSEcCtD
Remifentanil—Dysuria—Doxorubicin—uterine cancer	0.000415	0.00148	CcSEcCtD
Remifentanil—Sweating—Epirubicin—uterine cancer	0.00041	0.00147	CcSEcCtD
Remifentanil—Haematuria—Epirubicin—uterine cancer	0.000408	0.00146	CcSEcCtD
Remifentanil—Feeling abnormal—Etoposide—uterine cancer	0.000401	0.00143	CcSEcCtD
Remifentanil—Hyperglycaemia—Doxorubicin—uterine cancer	0.0004	0.00143	CcSEcCtD
Remifentanil—Nausea—Dactinomycin—uterine cancer	0.000399	0.00143	CcSEcCtD
Remifentanil—Pneumonia—Doxorubicin—uterine cancer	0.000398	0.00142	CcSEcCtD
Remifentanil—Bradycardia—Epirubicin—uterine cancer	0.000391	0.0014	CcSEcCtD
Remifentanil—Renal failure—Doxorubicin—uterine cancer	0.000389	0.00139	CcSEcCtD
Remifentanil—Urticaria—Etoposide—uterine cancer	0.000386	0.00138	CcSEcCtD
Remifentanil—Haemoglobin—Epirubicin—uterine cancer	0.000386	0.00138	CcSEcCtD
Remifentanil—Body temperature increased—Etoposide—uterine cancer	0.000384	0.00138	CcSEcCtD
Remifentanil—Haemorrhage—Epirubicin—uterine cancer	0.000384	0.00137	CcSEcCtD
Remifentanil—Pharyngitis—Epirubicin—uterine cancer	0.000381	0.00136	CcSEcCtD
Remifentanil—Sweating—Doxorubicin—uterine cancer	0.000379	0.00136	CcSEcCtD
Remifentanil—Haematuria—Doxorubicin—uterine cancer	0.000377	0.00135	CcSEcCtD
Remifentanil—Visual impairment—Epirubicin—uterine cancer	0.00037	0.00132	CcSEcCtD
Remifentanil—Bradycardia—Doxorubicin—uterine cancer	0.000361	0.00129	CcSEcCtD
Remifentanil—Hypersensitivity—Etoposide—uterine cancer	0.000358	0.00128	CcSEcCtD
Remifentanil—Haemoglobin—Doxorubicin—uterine cancer	0.000357	0.00128	CcSEcCtD
Remifentanil—Cardiac disorder—Epirubicin—uterine cancer	0.000356	0.00127	CcSEcCtD
Remifentanil—Flushing—Epirubicin—uterine cancer	0.000356	0.00127	CcSEcCtD
Remifentanil—Haemorrhage—Doxorubicin—uterine cancer	0.000355	0.00127	CcSEcCtD
Remifentanil—Pharyngitis—Doxorubicin—uterine cancer	0.000352	0.00126	CcSEcCtD
Remifentanil—Angiopathy—Epirubicin—uterine cancer	0.000348	0.00125	CcSEcCtD
Remifentanil—Immune system disorder—Epirubicin—uterine cancer	0.000347	0.00124	CcSEcCtD
Remifentanil—Mediastinal disorder—Epirubicin—uterine cancer	0.000346	0.00124	CcSEcCtD
Remifentanil—Chills—Epirubicin—uterine cancer	0.000344	0.00123	CcSEcCtD
Remifentanil—Pruritus—Etoposide—uterine cancer	0.000344	0.00123	CcSEcCtD
Remifentanil—Arrhythmia—Epirubicin—uterine cancer	0.000343	0.00123	CcSEcCtD
Remifentanil—Visual impairment—Doxorubicin—uterine cancer	0.000342	0.00122	CcSEcCtD
Remifentanil—Erythema—Epirubicin—uterine cancer	0.000334	0.00119	CcSEcCtD
Remifentanil—Diarrhoea—Etoposide—uterine cancer	0.000333	0.00119	CcSEcCtD
Remifentanil—Cardiac disorder—Doxorubicin—uterine cancer	0.00033	0.00118	CcSEcCtD
Remifentanil—Flushing—Doxorubicin—uterine cancer	0.00033	0.00118	CcSEcCtD
Remifentanil—Angiopathy—Doxorubicin—uterine cancer	0.000322	0.00115	CcSEcCtD
Remifentanil—Dizziness—Etoposide—uterine cancer	0.000322	0.00115	CcSEcCtD
Remifentanil—Immune system disorder—Doxorubicin—uterine cancer	0.000321	0.00115	CcSEcCtD
Remifentanil—Mediastinal disorder—Doxorubicin—uterine cancer	0.00032	0.00114	CcSEcCtD
Remifentanil—Chills—Doxorubicin—uterine cancer	0.000319	0.00114	CcSEcCtD
Remifentanil—Arrhythmia—Doxorubicin—uterine cancer	0.000317	0.00113	CcSEcCtD
Remifentanil—Vomiting—Etoposide—uterine cancer	0.000309	0.00111	CcSEcCtD
Remifentanil—Erythema—Doxorubicin—uterine cancer	0.000309	0.00111	CcSEcCtD
Remifentanil—Anaemia—Epirubicin—uterine cancer	0.000309	0.0011	CcSEcCtD
Remifentanil—Agitation—Epirubicin—uterine cancer	0.000307	0.0011	CcSEcCtD
Remifentanil—Rash—Etoposide—uterine cancer	0.000307	0.0011	CcSEcCtD
Remifentanil—Dermatitis—Etoposide—uterine cancer	0.000306	0.0011	CcSEcCtD
Remifentanil—Headache—Etoposide—uterine cancer	0.000305	0.00109	CcSEcCtD
Remifentanil—Syncope—Epirubicin—uterine cancer	0.0003	0.00107	CcSEcCtD
Remifentanil—Loss of consciousness—Epirubicin—uterine cancer	0.000294	0.00105	CcSEcCtD
Remifentanil—Cough—Epirubicin—uterine cancer	0.000292	0.00104	CcSEcCtD
Remifentanil—Convulsion—Epirubicin—uterine cancer	0.000289	0.00104	CcSEcCtD
Remifentanil—Nausea—Etoposide—uterine cancer	0.000289	0.00103	CcSEcCtD
Remifentanil—Hypertension—Epirubicin—uterine cancer	0.000288	0.00103	CcSEcCtD
Remifentanil—Anaemia—Doxorubicin—uterine cancer	0.000286	0.00102	CcSEcCtD
Remifentanil—Agitation—Doxorubicin—uterine cancer	0.000284	0.00102	CcSEcCtD
Remifentanil—Anxiety—Epirubicin—uterine cancer	0.000283	0.00101	CcSEcCtD
Remifentanil—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	0.000282	0.00101	CcSEcCtD
Remifentanil—Dry mouth—Epirubicin—uterine cancer	0.000278	0.000995	CcSEcCtD
Remifentanil—Syncope—Doxorubicin—uterine cancer	0.000277	0.000992	CcSEcCtD
Remifentanil—Confusional state—Epirubicin—uterine cancer	0.000275	0.000983	CcSEcCtD
Remifentanil—Oedema—Epirubicin—uterine cancer	0.000273	0.000975	CcSEcCtD
Remifentanil—Anaphylactic shock—Epirubicin—uterine cancer	0.000273	0.000975	CcSEcCtD
Remifentanil—Loss of consciousness—Doxorubicin—uterine cancer	0.000272	0.000972	CcSEcCtD
Remifentanil—Cough—Doxorubicin—uterine cancer	0.00027	0.000965	CcSEcCtD
Remifentanil—Shock—Epirubicin—uterine cancer	0.000268	0.000959	CcSEcCtD
Remifentanil—Convulsion—Doxorubicin—uterine cancer	0.000268	0.000958	CcSEcCtD
Remifentanil—Nervous system disorder—Epirubicin—uterine cancer	0.000267	0.000956	CcSEcCtD
Remifentanil—Thrombocytopenia—Epirubicin—uterine cancer	0.000267	0.000955	CcSEcCtD
Remifentanil—Hypertension—Doxorubicin—uterine cancer	0.000267	0.000955	CcSEcCtD
Remifentanil—Tachycardia—Epirubicin—uterine cancer	0.000266	0.000952	CcSEcCtD
Remifentanil—Skin disorder—Epirubicin—uterine cancer	0.000265	0.000947	CcSEcCtD
Remifentanil—Hyperhidrosis—Epirubicin—uterine cancer	0.000264	0.000943	CcSEcCtD
Remifentanil—Anxiety—Doxorubicin—uterine cancer	0.000262	0.000938	CcSEcCtD
Remifentanil—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	0.000261	0.000935	CcSEcCtD
Remifentanil—Dry mouth—Doxorubicin—uterine cancer	0.000257	0.000921	CcSEcCtD
Remifentanil—Hypotension—Epirubicin—uterine cancer	0.000255	0.000911	CcSEcCtD
Remifentanil—Confusional state—Doxorubicin—uterine cancer	0.000254	0.00091	CcSEcCtD
Remifentanil—Anaphylactic shock—Doxorubicin—uterine cancer	0.000252	0.000902	CcSEcCtD
Remifentanil—Oedema—Doxorubicin—uterine cancer	0.000252	0.000902	CcSEcCtD
Remifentanil—Shock—Doxorubicin—uterine cancer	0.000248	0.000888	CcSEcCtD
Remifentanil—Nervous system disorder—Doxorubicin—uterine cancer	0.000247	0.000885	CcSEcCtD
Remifentanil—Thrombocytopenia—Doxorubicin—uterine cancer	0.000247	0.000884	CcSEcCtD
Remifentanil—Tachycardia—Doxorubicin—uterine cancer	0.000246	0.000881	CcSEcCtD
Remifentanil—Skin disorder—Doxorubicin—uterine cancer	0.000245	0.000877	CcSEcCtD
Remifentanil—Paraesthesia—Epirubicin—uterine cancer	0.000245	0.000876	CcSEcCtD
Remifentanil—Hyperhidrosis—Doxorubicin—uterine cancer	0.000244	0.000872	CcSEcCtD
Remifentanil—Dyspnoea—Epirubicin—uterine cancer	0.000243	0.000869	CcSEcCtD
Remifentanil—Somnolence—Epirubicin—uterine cancer	0.000242	0.000867	CcSEcCtD
Remifentanil—Dyspepsia—Epirubicin—uterine cancer	0.00024	0.000858	CcSEcCtD
Remifentanil—Hypotension—Doxorubicin—uterine cancer	0.000236	0.000843	CcSEcCtD
Remifentanil—Gastrointestinal disorder—Epirubicin—uterine cancer	0.000235	0.000842	CcSEcCtD
Remifentanil—Constipation—Epirubicin—uterine cancer	0.000233	0.000834	CcSEcCtD
Remifentanil—Pain—Epirubicin—uterine cancer	0.000233	0.000834	CcSEcCtD
Remifentanil—Paraesthesia—Doxorubicin—uterine cancer	0.000227	0.00081	CcSEcCtD
Remifentanil—Dyspnoea—Doxorubicin—uterine cancer	0.000225	0.000805	CcSEcCtD
Remifentanil—Feeling abnormal—Epirubicin—uterine cancer	0.000225	0.000804	CcSEcCtD
Remifentanil—Somnolence—Doxorubicin—uterine cancer	0.000224	0.000802	CcSEcCtD
Remifentanil—Dyspepsia—Doxorubicin—uterine cancer	0.000222	0.000794	CcSEcCtD
Remifentanil—Gastrointestinal disorder—Doxorubicin—uterine cancer	0.000218	0.000779	CcSEcCtD
Remifentanil—Urticaria—Epirubicin—uterine cancer	0.000217	0.000775	CcSEcCtD
Remifentanil—Pain—Doxorubicin—uterine cancer	0.000216	0.000772	CcSEcCtD
Remifentanil—Constipation—Doxorubicin—uterine cancer	0.000216	0.000772	CcSEcCtD
Remifentanil—Body temperature increased—Epirubicin—uterine cancer	0.000216	0.000771	CcSEcCtD
Remifentanil—Feeling abnormal—Doxorubicin—uterine cancer	0.000208	0.000744	CcSEcCtD
Remifentanil—Hypersensitivity—Epirubicin—uterine cancer	0.000201	0.000719	CcSEcCtD
Remifentanil—Urticaria—Doxorubicin—uterine cancer	0.0002	0.000717	CcSEcCtD
Remifentanil—Body temperature increased—Doxorubicin—uterine cancer	0.000199	0.000713	CcSEcCtD
Remifentanil—Pruritus—Epirubicin—uterine cancer	0.000193	0.00069	CcSEcCtD
Remifentanil—Diarrhoea—Epirubicin—uterine cancer	0.000187	0.000667	CcSEcCtD
Remifentanil—Hypersensitivity—Doxorubicin—uterine cancer	0.000186	0.000665	CcSEcCtD
Remifentanil—Dizziness—Epirubicin—uterine cancer	0.00018	0.000645	CcSEcCtD
Remifentanil—Pruritus—Doxorubicin—uterine cancer	0.000178	0.000638	CcSEcCtD
Remifentanil—Vomiting—Epirubicin—uterine cancer	0.000173	0.00062	CcSEcCtD
Remifentanil—Diarrhoea—Doxorubicin—uterine cancer	0.000173	0.000617	CcSEcCtD
Remifentanil—Rash—Epirubicin—uterine cancer	0.000172	0.000615	CcSEcCtD
Remifentanil—Dermatitis—Epirubicin—uterine cancer	0.000172	0.000614	CcSEcCtD
Remifentanil—Headache—Epirubicin—uterine cancer	0.000171	0.000611	CcSEcCtD
Remifentanil—Dizziness—Doxorubicin—uterine cancer	0.000167	0.000597	CcSEcCtD
Remifentanil—Nausea—Epirubicin—uterine cancer	0.000162	0.000579	CcSEcCtD
Remifentanil—Vomiting—Doxorubicin—uterine cancer	0.00016	0.000574	CcSEcCtD
Remifentanil—Rash—Doxorubicin—uterine cancer	0.000159	0.000569	CcSEcCtD
Remifentanil—Dermatitis—Doxorubicin—uterine cancer	0.000159	0.000568	CcSEcCtD
Remifentanil—Headache—Doxorubicin—uterine cancer	0.000158	0.000565	CcSEcCtD
Remifentanil—Nausea—Doxorubicin—uterine cancer	0.00015	0.000536	CcSEcCtD
